bhavana

 The report " Antifungal Drugs Market By Drug Class (Azoles, Polyenes, Echinocandins, Allylamines, Others), By Route of Administration (Oral, Parenteral, Topical), By Therapeutic Indications (Aspergillosis, Candidiasis, Dermatophytosis, Others), By Distribution Channel (Retail Pharmacies, Hospital pharmacies, Drug stores, Online pharmacies), and Region - Global Forecasts to 2030", is projected to reach USD 15,812.5 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period 2024-2030. The growth of the antifungal drugs market is majorly driven by the rising consumption of antifungal drugs in developing regions. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=15770 Competitive Dashboard: The prominent key players operating in the global antifungal drugs market are Pfizer, Inc. (U.S.) Novartis AG (Switzerland) Sanofi (France) Merck & Co., Inc. (U.S.) Enzon Pharmaceuticals, Inc....

  The global antifungal drugs market size was valued at USD 15,623.8 million in 2022 and is poised to grow at a significant CAGR of 3.9% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and further split by nations and categories within each region. The research also includes factors and barriers to the antifungal drugs market growth , as well as their impact on the market's future growth. The report gives a comprehensive overview of both primary and secondary data.     View the detailed report description here - https://precisionbusinessinsights.com/market-reports/global-anti-fungal-drugs-market The global antifungal drugs market segmentation: 1) By Drug Class: Azoles, Polyenes, Echinocandins, Allyl...